20 Oct Proposed Regulation on Premium Cigars Moves to Next Phase
WASHINGTON, D.C. –The Food and Drug Administration (FDA) has moved the proposed deeming rule on cigars and pipe tobacco into the next phase by sending it to Office of Management and Budget (OMB) at the White House for economic review as required by Executive Order 12866.
This agency has a statutory 90-day period for review before the rule is moved into final implementation. During this time, the IPCPR will present fact based evidence and data to the Administration. OMB will likely not share the details as they review the FDA’s proposal. As such, the IPCPR is prepared to act immediately upon release of the final rule should the ruling not be favorable to premium cigars and pipe tobacco.
Under the Tobacco Control Act, the FDA has the authority to regulate tobacco-derived products in the U.S. marketplace. The IPCPR believes that premium cigars should be exempt from regulation as they do not have youth access issues and habitual use patterns which was the scope of the original Tobacco Control Act, passed by Congress in 2009.
Your cooperation and participation as a member of the IPCPR is crucial during this time. Please contact your Member of Congress to encourage their support. If you have any questions or concerns, please contact our Senior Director of Federal Legislative Affairs, Kip Talley at Kip@ipcpr.org.